Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02208414
Collaborator
(none)
80
1
2
30
2.7

Study Details

Study Description

Brief Summary

Purpose of this study is to determine whether NAET procedures are effective in the treatment of crab or shrimp allergy.

Hypothesis: experimental group will show a significant improvement over the control group in allergic symptom, serum crab- or shrimp-specific IgE and skin test for crab or shrimp extract.

Condition or Disease Intervention/Treatment Phase
  • Procedure: NAET
  • Procedure: NAET
N/A

Detailed Description

Nambudripad allergy elimination techniques (NAET) were developed by Dr. Devi Nambudripad in 1983. Many patients have been relieved of allergy and allergy-related disease by this treatment.

Lack of well-controlled clinical study prevents NAET from being accepted as a treatment option in current medical system.

The aim of this project is to conduct a double blind-placebo controlled study of applying NAET to treat crab or shrimp allergy.

The parameters to be measured are allergic symptom, crab- or shrimp-specific IgE and skin test before and after NAET treatment

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
A Randomized Double-Blind Placebo-Controlled Crab Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques in NTU Campus
Study Start Date :
Jun 1, 2012
Actual Primary Completion Date :
Jul 1, 2014
Anticipated Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Crab or shrimp

Intervention: treated with crab and shrimp energy signature vial using NAET

Procedure: NAET
NAET with acupressure and/or chiropractic procedures with the participant holding crab and shrimp energy signature vial

Placebo Comparator: Placebo

Treated with water vial

Procedure: NAET
NAET with acupressure and/or chiropractic procedures with the participant holding water vial

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline in allergic symptoms at 6 months [before NAET and 6 months after NAET]

    Symptoms when exposed to crab or shrimp which include symptoms of skin, eye, respiratory tract, gastrointestinal tract, cardiovascular system and others. The participants give score subjectively from 0 to 10 according to the severity of the symptoms.

Secondary Outcome Measures

  1. Serum crab- or shrimp-specific IgE [before NAET, 1 month, 3 months and 6 months after NAET]

  2. Skin test [before NAET, 1 month and 6 months after NAET]

    Skin test for crab or shrimp extract

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Older or equal to 20 years old

  • History of allergic to crab or shrimp

  • Positive serum crab- or shrimp-specific IgE

Exclusion Criteria:
  • History of anaphylactic shock

  • On medication of anti-histamine or steroid

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Taiwan University Hospital Taipei Taiwan 100

Sponsors and Collaborators

  • National Taiwan University Hospital

Investigators

  • Principal Investigator: Cha Ze Lee, MD, PhD, National Taiwan University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT02208414
Other Study ID Numbers:
  • 201111069RID
First Posted:
Aug 5, 2014
Last Update Posted:
Aug 5, 2014
Last Verified:
Aug 1, 2014
Keywords provided by National Taiwan University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 5, 2014